Title:
Development of a producer cell line for making Adeno-associated virus for gene therapy purposes
Agreement Value:
$200,000.00
Agreement Date:
Mar 20, 2020 - Mar 31, 2022
Description:
The objective of this two-year project is the construction of a new generation of inducible packaging cell line based on the HEK293 cell line for the production of adeno-associated virus (AAV). This would allow for a cheaper and more efficient method of production than the currently existing method, possibly yielding higher titers of AAVs.
Organization:
National Research Council Canada
Expected Results:
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.
Location:
Québec, Quebec, CA G1V 0A6
Reference Number:
172-2019-2020-Q4-947372
Report Type:
Grants and Contributions
Recipient Business Number:
119278950
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 183 days. The total amended value is 8,600 dollars.
Recipient's Operating Name:
Université Laval
Recipient's Legal Name:
Université Laval
Federal Riding Name:
Louis-Hébert
Federal Riding Number:
24044
Program:
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Program Purpose:
Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.